Product sourcing reference

HGH Fragment 176-191

A 16-residue fragment of growth hormone with an internal disulfide bond. Confirm the exact sequence and handling requirements before adding it to a request.

Reference variants

Add HGH Fragment 176-191 to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

10mgVial · confirm physical formCAS 66004-57-7

Quote requiredReference listed as discontinued. Historical reference $12.94/vial; not an offer.
Ask for a quote

Review your order request · Compare the full catalog

Confirm the exact substance

HGH Fragment 176-191 is not growth hormone and does not carry the same receptor activity. Its lipolysis research has not produced an approved product.

What the review will ask

The reference lists this item as discontinued, so it is shown for comparison only. Contact us if you need a quote; we do not assume it can be supplied.

State the facility type, destination state and intended transaction. Do not send patient information.
Expect product- and lot-specific documentation to be requested before any material is accepted.
A listed price is a reference estimate. Availability, labeling, shipping and terms are confirmed in writing only after review.

Purchasing questions

Can I request HGH Fragment 176-191 online?

Not at present. It is marked quote required because the reference source lists it as discontinued. Contact us to discuss whether any supply exists.

Resolve the fragment before a quote

This quote-only reference should not be compared with full growth hormone or AOD-9604 based only on a shared category. The source's discontinued status is not evidence of another supplier's stock.

Documentation to request

Ask for the exact residue sequence and modifications, then obtain written availability only if a permitted transaction can be established.

Regulatory context: FDA: compounding, approval and quality standards. Source reviewed 2026-10-16. This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Longevity clinic documentation questions. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. This reference is not medical or legal advice and does not establish a lawful supply route.

Discuss sourcing requirements